Focus Partners Wealth’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.7M Buy
20,933
+5,183
+33% +$1.29M 0.01% 958
2025
Q4
$3.79M Buy
15,750
+5,543
+54% +$1.42M ﹤0.01% 1052
2025
Q3
$2.79M Sell
10,207
-505
-5% -$138K ﹤0.01% 918
2025
Q2
$2.76M Sell
10,712
-704
-6% -$168K 0.01% 820
2025
Q1
$2.56M Sell
11,416
-195
-2% -$45.5K 0.01% 787
2024
Q4
$2.66M Buy
11,611
+7,703
+197% +$1.85M 0.01% 778
2024
Q3
$954K Sell
3,908
-734
-16% -$164K ﹤0.01% 956
2024
Q2
$888K Buy
+4,642
New +$942K ﹤0.01% 820

Other funds holding RMD

Focus Partners Wealth's RMD Position: Q1 2026 in Review

Focus Partners Wealth increased its ResMed (RMD) stake by 33% in Q1 2026, buying an estimated $1.29M and bringing the position to 20,933 shares worth $4.7M. The position accounts for 0.01% of the portfolio, ranked #958.

Focus Partners Wealth first reported a position in RMD in Q2 2024 and has held it in 8 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Focus Partners Wealth held 20,933 shares of ResMed worth $4.7M as of Q1 2026.
  • Focus Partners Wealth bought 5,183 ResMed shares in Q1 2026, an estimated $1.29M.
  • ResMed made up 0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #958 holding.
  • Focus Partners Wealth first reported a position in ResMed in Q2 2024 and has held it in 8 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.